Alphons J.M. Vermorken

Prof. Dr. Alphons J.M. Vermorken

orcid

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2013 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
Emmanuel AndrèsEmmanuel Andrès
Emmanuel Andrès
KSK. Serraj
K. Serraj
JZJingjing Zhu
Jingjing Zhu
AVAlphons J.M. Vermorken
Alphons J.M. Vermorken
Hypercobalaminemia (high serum vitamin B12 levels) is a frequent and underestimated anomaly. Clinically, it can be paradoxically accompanied by signs of deficiency, reflecting a functional deficiency linked to qualitative abnormalities, which are related to defects in tissue uptake and action of vitamin B12. The aetiological profile of high serum cobalamin predominantly encompasses severe disease entities for which early diagnosis is critical for prognosis. These entities are essentially comprised of solid neoplasms, haematological malignancies and liver and kidney diseases. This review reflects the potential importance of the vitamin B12 assay as an early diagnostic marker of these diseases. A codified approach is needed to determine the potential indications of a search for high serum cobalamin and the practical clinical strategy to adopt upon discovery of elevated cobalamin levels. While low serum cobalamin levels do not necessarily imply deficiency, an abnormally high serum cobalamin level forms a warning sign requiring exclusion of a number of serious underlying pathologies. Functional cobalamin deficiency can thus occur at any serum level.

1 December 1976 in Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes
Verified
Journal Article
Closed access
EBE.L. Benedetti
E.L. Benedetti
IDI. Dunia
I. Dunia
CBC.J. Bentzel
C.J. Bentzel
AVAlphons J.M. Vermorken
Alphons J.M. Vermorken
MKM. Kibbelaar
M. Kibbelaar
HBH. Bloemendal
H. Bloemendal

18 May 2015 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MPMingli Peng
Mingli Peng
HLHouli Li
Houli Li
ZLZhiyi Luo
Zhiyi Luo
JKJian Kong
Jian Kong
YWYinsheng Wan
Yinsheng Wan
YCYali Cui
Yali Cui
Dextran-coated superparamagnetic iron oxide nanoparticles (DSPIONs) have gained considerable interest, because of their biocompatibility and biosafety in clinics. Doxorubicin (Dox), a widely used chemotherapeutic drug, always has limited applications in clinical therapy due to its serious side effects of dose-limiting irreversible cardiotoxicity and myelo suppression. Herein, DSPIONs were synthesized and developed as magnetic carriers for doxorubicin. The Dox–DSPION conjugates were evaluated in the in vitro test of Dox release, which showed pH-dependence with the highest release percentage of 50.3% at pH 5.0 and the lowest release percentage of 11.8% in a physiological environment. The cytotoxicity of DSPIONs and Dox–DSPIONs evaluated by the MTT assay indicated that DSPIONs had no cytotoxicity and the conjugates had significantly reduced the toxicity (IC50 = 1.36 μg mL−1) compared to free Dox (IC50 = 0.533 μg mL−1). Furthermore, confocal microscopic data of cell uptake suggest that less cytotoxicity of Dox–DSPIONs may be attributed to the cellular internalization of the conjugates and sustainable release of Dox from the formulation in the cytoplasm. More importantly, the results from the rabbit VX2 liver tumor model test under an external magnetic field showed that the conjugates had approximately twice the anti-tumor activity and two and a half times the animal survival rate, respectively, compared to free Dox. Collectively, our data have demonstrated that Dox–DSPIONs have less toxicity with better antitumor effectiveness in in vitro and in vivo applications, suggesting that the conjugates have potential to be developed into chemo-therapeutic formulations.

1 January 1981 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PWP.J.J.M. Weterings
P.J.J.M. Weterings
AVAlphons J.M. Vermorken
Alphons J.M. Vermorken
HBH. Bloemendal
H. Bloemendal

1 July 2019 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
QZQinlu Zhang
Qinlu Zhang
QLQian Liu
Qian Liu
MDMenghan Du
Menghan Du
AVAlphons J.M. Vermorken
Alphons J.M. Vermorken
YCYali Cui
Yali Cui
MCMingwei Chen
Mingwei Chen

1 April 1977 in Experimental Eye Research
Verified
Journal Article
Closed access
HBH. Bloemendal
H. Bloemendal
AVAlphons J.M. Vermorken
Alphons J.M. Vermorken
MKM. Kibbelaar
M. Kibbelaar
IDI. Dunia
I. Dunia
EBE.L. Benedetti
E.L. Benedetti